Pulmonary/ Respiratory Drug Delivery Market, Global Outlook and Forecast 2024-2031

Report ID: 1139848 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Pulmonary/ Respiratory Drug Delivery Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Pulmonary/ Respiratory Drug Delivery Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Pulmonary/ Respiratory Drug Delivery Overall Market Size
    2.1 Global Pulmonary/ Respiratory Drug Delivery Market Size: 2021 VS 2028
    2.2 Global Pulmonary/ Respiratory Drug Delivery Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Pulmonary/ Respiratory Drug Delivery Players in Global Market
    3.2 Top Global Pulmonary/ Respiratory Drug Delivery Companies Ranked by Revenue
    3.3 Global Pulmonary/ Respiratory Drug Delivery Revenue by Companies
    3.4 Top 3 and Top 5 Pulmonary/ Respiratory Drug Delivery Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Pulmonary/ Respiratory Drug Delivery Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Pulmonary/ Respiratory Drug Delivery Players in Global Market
        3.6.1 List of Global Tier 1 Pulmonary/ Respiratory Drug Delivery Companies
        3.6.2 List of Global Tier 2 and Tier 3 Pulmonary/ Respiratory Drug Delivery Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Pulmonary/ Respiratory Drug Delivery Market Size Markets, 2021 & 2028
        4.1.2 Suspension Aerosol
        4.1.3 Solution Aerosol
        4.1.4 Dry Powder Formulation
    4.2 By Type - Global Pulmonary/ Respiratory Drug Delivery Revenue & Forecasts
        4.2.1 By Type - Global Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2022
        4.2.2 By Type - Global Pulmonary/ Respiratory Drug Delivery Revenue, 2023-2028
        4.2.3 By Type - Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Pulmonary/ Respiratory Drug Delivery Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Home Care
    5.2 By Application - Global Pulmonary/ Respiratory Drug Delivery Revenue & Forecasts
        5.2.1 By Application - Global Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2022
        5.2.2 By Application - Global Pulmonary/ Respiratory Drug Delivery Revenue, 2023-2028
        5.2.3 By Application - Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Pulmonary/ Respiratory Drug Delivery Market Size, 2021 & 2028
    6.2 By Region - Global Pulmonary/ Respiratory Drug Delivery Revenue & Forecasts
        6.2.1 By Region - Global Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2022
        6.2.2 By Region - Global Pulmonary/ Respiratory Drug Delivery Revenue, 2023-2028
        6.2.3 By Region - Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2028
        6.3.2 US Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.3.3 Canada Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.3.4 Mexico Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2028
        6.4.2 Germany Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.4.3 France Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.4.4 U.K. Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.4.5 Italy Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.4.6 Russia Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.4.7 Nordic Countries Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.4.8 Benelux Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2028
        6.5.2 China Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.5.3 Japan Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.5.4 South Korea Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.5.5 Southeast Asia Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.5.6 India Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2028
        6.6.2 Brazil Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.6.3 Argentina Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2028
        6.7.2 Turkey Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.7.3 Israel Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.7.4 Saudi Arabia Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
        6.7.5 UAE Pulmonary/ Respiratory Drug Delivery Market Size, 2017-2028
7 Players Profiles
    7.1 Merck
        7.1.1 Merck Corporate Summary
        7.1.2 Merck Business Overview
        7.1.3 Merck Pulmonary/ Respiratory Drug Delivery Major Product Offerings
        7.1.4 Merck Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
        7.1.5 Merck Key News
    7.2 Teva Pharmaceutical
        7.2.1 Teva Pharmaceutical Corporate Summary
        7.2.2 Teva Pharmaceutical Business Overview
        7.2.3 Teva Pharmaceutical Pulmonary/ Respiratory Drug Delivery Major Product Offerings
        7.2.4 Teva Pharmaceutical Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
        7.2.5 Teva Pharmaceutical Key News
    7.3 3M
        7.3.1 3M Corporate Summary
        7.3.2 3M Business Overview
        7.3.3 3M Pulmonary/ Respiratory Drug Delivery Major Product Offerings
        7.3.4 3M Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
        7.3.5 3M Key News
    7.4 Astrazeneca
        7.4.1 Astrazeneca Corporate Summary
        7.4.2 Astrazeneca Business Overview
        7.4.3 Astrazeneca Pulmonary/ Respiratory Drug Delivery Major Product Offerings
        7.4.4 Astrazeneca Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
        7.4.5 Astrazeneca Key News
    7.5 Boehringer Ingelheim
        7.5.1 Boehringer Ingelheim Corporate Summary
        7.5.2 Boehringer Ingelheim Business Overview
        7.5.3 Boehringer Ingelheim Pulmonary/ Respiratory Drug Delivery Major Product Offerings
        7.5.4 Boehringer Ingelheim Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
        7.5.5 Boehringer Ingelheim Key News
    7.6 Cipla
        7.6.1 Cipla Corporate Summary
        7.6.2 Cipla Business Overview
        7.6.3 Cipla Pulmonary/ Respiratory Drug Delivery Major Product Offerings
        7.6.4 Cipla Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
        7.6.5 Cipla Key News
    7.7 Glaxosmithkline
        7.7.1 Glaxosmithkline Corporate Summary
        7.7.2 Glaxosmithkline Business Overview
        7.7.3 Glaxosmithkline Pulmonary/ Respiratory Drug Delivery Major Product Offerings
        7.7.4 Glaxosmithkline Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
        7.7.5 Glaxosmithkline Key News
    7.8 Novartis
        7.8.1 Novartis Corporate Summary
        7.8.2 Novartis Business Overview
        7.8.3 Novartis Pulmonary/ Respiratory Drug Delivery Major Product Offerings
        7.8.4 Novartis Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
        7.8.5 Novartis Key News
    7.9 Omron Corporation
        7.9.1 Omron Corporation Corporate Summary
        7.9.2 Omron Corporation Business Overview
        7.9.3 Omron Corporation Pulmonary/ Respiratory Drug Delivery Major Product Offerings
        7.9.4 Omron Corporation Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
        7.9.5 Omron Corporation Key News
    7.10 Sunovion Pharmaceuticals
        7.10.1 Sunovion Pharmaceuticals Corporate Summary
        7.10.2 Sunovion Pharmaceuticals Business Overview
        7.10.3 Sunovion Pharmaceuticals Pulmonary/ Respiratory Drug Delivery Major Product Offerings
        7.10.4 Sunovion Pharmaceuticals Pulmonary/ Respiratory Drug Delivery Revenue in Global Market (2017-2022)
        7.10.5 Sunovion Pharmaceuticals Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Pulmonary/ Respiratory Drug Delivery Market Opportunities & Trends in Global Market
    Table 2. Pulmonary/ Respiratory Drug Delivery Market Drivers in Global Market
    Table 3. Pulmonary/ Respiratory Drug Delivery Market Restraints in Global Market
    Table 4. Key Players of Pulmonary/ Respiratory Drug Delivery in Global Market
    Table 5. Top Pulmonary/ Respiratory Drug Delivery Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Pulmonary/ Respiratory Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Pulmonary/ Respiratory Drug Delivery Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Pulmonary/ Respiratory Drug Delivery Product Type
    Table 9. List of Global Tier 1 Pulmonary/ Respiratory Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Pulmonary/ Respiratory Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Pulmonary/ Respiratory Drug Delivery Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Pulmonary/ Respiratory Drug Delivery Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Pulmonary/ Respiratory Drug Delivery Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Pulmonary/ Respiratory Drug Delivery Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2023-2028
    Table 30. Merck Corporate Summary
    Table 31. Merck Pulmonary/ Respiratory Drug Delivery Product Offerings
    Table 32. Merck Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 33. Teva Pharmaceutical Corporate Summary
    Table 34. Teva Pharmaceutical Pulmonary/ Respiratory Drug Delivery Product Offerings
    Table 35. Teva Pharmaceutical Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 36. 3M Corporate Summary
    Table 37. 3M Pulmonary/ Respiratory Drug Delivery Product Offerings
    Table 38. 3M Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 39. Astrazeneca Corporate Summary
    Table 40. Astrazeneca Pulmonary/ Respiratory Drug Delivery Product Offerings
    Table 41. Astrazeneca Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 42. Boehringer Ingelheim Corporate Summary
    Table 43. Boehringer Ingelheim Pulmonary/ Respiratory Drug Delivery Product Offerings
    Table 44. Boehringer Ingelheim Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 45. Cipla Corporate Summary
    Table 46. Cipla Pulmonary/ Respiratory Drug Delivery Product Offerings
    Table 47. Cipla Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 48. Glaxosmithkline Corporate Summary
    Table 49. Glaxosmithkline Pulmonary/ Respiratory Drug Delivery Product Offerings
    Table 50. Glaxosmithkline Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 51. Novartis Corporate Summary
    Table 52. Novartis Pulmonary/ Respiratory Drug Delivery Product Offerings
    Table 53. Novartis Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 54. Omron Corporation Corporate Summary
    Table 55. Omron Corporation Pulmonary/ Respiratory Drug Delivery Product Offerings
    Table 56. Omron Corporation Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 57. Sunovion Pharmaceuticals Corporate Summary
    Table 58. Sunovion Pharmaceuticals Pulmonary/ Respiratory Drug Delivery Product Offerings
    Table 59. Sunovion Pharmaceuticals Pulmonary/ Respiratory Drug Delivery Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Pulmonary/ Respiratory Drug Delivery Segment by Type in 2021
    Figure 2. Pulmonary/ Respiratory Drug Delivery Segment by Application in 2021
    Figure 3. Global Pulmonary/ Respiratory Drug Delivery Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Pulmonary/ Respiratory Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Pulmonary/ Respiratory Drug Delivery Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Pulmonary/ Respiratory Drug Delivery Revenue in 2021
    Figure 8. By Type - Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
    Figure 12. US Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
    Figure 16. Germany Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 17. France Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
    Figure 24. China Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 28. India Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
    Figure 30. Brazil Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Pulmonary/ Respiratory Drug Delivery Revenue Market Share, 2017-2028
    Figure 33. Turkey Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Pulmonary/ Respiratory Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 37. Merck Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Teva Pharmaceutical Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. 3M Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Astrazeneca Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Boehringer Ingelheim Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Cipla Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Glaxosmithkline Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Novartis Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Omron Corporation Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Sunovion Pharmaceuticals Pulmonary/ Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
67
Frequently Asked Questions
Pulmonary/ Respiratory Drug Delivery Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pulmonary/ Respiratory Drug Delivery Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pulmonary/ Respiratory Drug Delivery Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports